{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:37:41Z","timestamp":1778535461782,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12149-024-02011-6","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:00:55Z","timestamp":1737079255000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-751X","authenticated-orcid":false,"given":"Ba\u015fak","family":"Soyda\u015f-Turan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Fani","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca","family":"Eldem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Peynircioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Ugur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge","family":"Volkan-Salanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"2011_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.semnuclmed.2016.01.008","volume":"46","author":"MF Bozkurt","year":"2016","unstructured":"Bozkurt MF, Salanci BV, U\u011fur \u00d6. Intra-arterial radionuclide therapies for liver tumors. Semin Nucl Med. 2016;46:324\u201339.","journal-title":"Semin Nucl Med"},{"key":"2011_CR2","first-page":"969","volume":"30","author":"C Breedis","year":"1954","unstructured":"Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30:969.","journal-title":"Am J Pathol"},{"key":"2011_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13566-016-0282-3","volume":"6","author":"NP Burnett","year":"2017","unstructured":"Burnett NP, Akinwande O, Scoggins CR, McMasters KM, Philips P, Martin RC. Comparison of Yttrium-90 therapy for unresectable liver metastasis: glass versus biocompatible resin microspheres. J Radiat Oncol. 2017;6:101\u20138.","journal-title":"J Radiat Oncol"},{"key":"2011_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jso.20609","volume":"94","author":"LM Kulik","year":"2006","unstructured":"Kulik LM, Atassi B, Van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, et al. Yttrium-90 microspheres (TheraSphere\u00ae) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J S Oncol. 2006;94:572\u201386.","journal-title":"J S Oncol"},{"key":"2011_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.sla.0000133123.11932.19","volume":"240","author":"W Lau","year":"2004","unstructured":"Lau W, Ho SK, Simon C, Lai EC, Liew C, Leung TW. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg. 2004;240:299.","journal-title":"Ann Surg"},{"key":"2011_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejso.2014.09.007","volume":"41","author":"D Al-Adra","year":"2015","unstructured":"Al-Adra D, Gill R, Axford S, Shi X, Kneteman N, Liau S-S. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. Eur J Surg Oncol. 2015;41:120\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"2011_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fonc.2014.00120","volume":"4","author":"M Raval","year":"2014","unstructured":"Raval M, Bande D, Pillai AK, Blaszkowsky LS, Ganguli S, Beg MS, et al. Yttrium-90 radioembolization of hepatic metastases from colorectal cancer. Front Oncol. 2014;4:120.","journal-title":"Front Oncol"},{"key":"2011_CR8","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1245\/s10434-013-3436-1","volume":"21","author":"A Saxena","year":"2014","unstructured":"Saxena A, Kapoor J, Meteling B, Morris DL, Bester L. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients. Ann Surg Oncol. 2014;21:1296\u2013303.","journal-title":"Ann Surg Oncol"},{"key":"2011_CR9","unstructured":"SIR-Spheres Yttrium-90 microspheres [package insert]. Lane Cove, Australia: Sirtex Medical, 2004."},{"key":"2011_CR10","unstructured":"TheraSphere Yttrium-90 microspheres [package insert]. Kanata, ON, Canada: MDS Nordion, 2004."},{"key":"2011_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550\u20138.","journal-title":"J Clin Oncol"},{"key":"2011_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jvir.2016.01.147","volume":"27","author":"DM Biederman","year":"2016","unstructured":"Biederman DM, Titano JJ, Tabori NE, Pierobon ES, Alshebeeb K, Schwartz M, et al. Outcomes of radioembolization in the treatment of hepatocellular carcinoma with portal vein invasion: resin versus glass microspheres. J Vasc Interv Radiol. 2016;27:812-21. e2.","journal-title":"J Vasc Interv Radiol"},{"key":"2011_CR13","doi-asserted-by":"publisher","DOI":"10.23736\/S1824-4785.22.03452-5","author":"MN Braat","year":"2022","unstructured":"Braat MN, Braat AJ, Lam MG. Toxicity comparison of yttrium-90 resin and glass microspheres radioembolization. Q J Nucl Med Mol Imaging. 2022. https:\/\/doi.org\/10.23736\/S1824-4785.22.03452-5.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2011_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.21037\/jgo.2016.03.09","volume":"7","author":"SM Srinivas","year":"2016","unstructured":"Srinivas SM, Nasr EC, Kunam VK, Bullen JA, Purysko AS. Administered activity and outcomes of glass versus resin 90Y microsphere radioembolization in patients with colorectal liver metastases. J Gastrointest Oncol. 2016;7:530.","journal-title":"J Gastrointest Oncol"},{"key":"2011_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00270-013-0742-8","volume":"37","author":"MG Lam","year":"2014","unstructured":"Lam MG, Banerjee A, Louie JD, Sze DY. Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization. Cardiovasc Interv Radiol. 2014;37:1009\u201317.","journal-title":"Cardiovasc Interv Radiol"},{"key":"2011_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/bjc.2016.33","volume":"114","author":"H Toyoda","year":"2016","unstructured":"Toyoda H, Lai PB, O\u2019Beirne J, Chong CC, Berhane S, Reeves H, et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer. 2016;114:744\u201350.","journal-title":"Br J Cancer"},{"key":"2011_CR17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10637-015-0292-9","volume":"33","author":"S Ogasawara","year":"2015","unstructured":"Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, et al. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Investig New Drugs. 2015;33:1257\u201362.","journal-title":"Investig New Drugs"},{"key":"2011_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"YY Wang","year":"2016","unstructured":"Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103:725\u201334.","journal-title":"Br J Surg"},{"key":"2011_CR19","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/jso.24992","volume":"117","author":"SK Na","year":"2018","unstructured":"Na SK, Yim SY, Suh SJ, Jung YK, Kim JH, Seo YS, et al. ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma. J Surg Oncol. 2018;117:912\u201321.","journal-title":"J Surg Oncol"},{"key":"2011_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100348","volume":"7","author":"K Takada","year":"2022","unstructured":"Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, et al. Assessment of the albumin\u2013bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2022;7: 100348.","journal-title":"ESMO Open"},{"key":"2011_CR21","doi-asserted-by":"crossref","unstructured":"Imamura T, Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, et al. Clinical significance of preoperative Albumin\u2013Bilirubin grade in pancreatic cancer. Ann Surg Oncol 2021:1\u201313.","DOI":"10.1245\/s10434-021-09593-9"},{"key":"2011_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/hepr.13673","volume":"51","author":"S Kaneko","year":"2021","unstructured":"Kaneko S, Kurosaki M, Tsuchiya K, Yasui Y, Inada K, Kirino S, et al. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin\u2013bilirubin grade. Hepatol Res. 2021;51:902\u20138.","journal-title":"Hepatol Res"},{"key":"2011_CR23","doi-asserted-by":"crossref","unstructured":"Zhu C, Wang X, Chen S, Yang X, Sun J, Pan B, et al. Efficacy of the preoperative albumin\u2013bilirubin grade for predicting survival and outcomes of postoperative chemotherapy for advanced gastric cancer. Cancer Manag Res. 2020:11921\u201332.","DOI":"10.2147\/CMAR.S279782"},{"key":"2011_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.4143\/crt.2022.1444","volume":"55","author":"D Kim","year":"2023","unstructured":"Kim D, Lee J-H, Cho E-S, Shin S-J, Lee HS, Koh H-H, et al. Clinical significance of combining preoperative and postoperative albumin-bilirubin score in colorectal cancer. Cancer Res Treat. 2023;55:1261\u20139.","journal-title":"Cancer Res Treat"},{"key":"2011_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21772","volume":"9","author":"L Chen","year":"2023","unstructured":"Chen L, Tan C, Li Q, Ma Z, Wu M, Tan X, et al. Assessment of the albumin\u2013bilirubin score in breast cancer patients with liver metastasis after surgery. Heliyon. 2023;9: e21772.","journal-title":"Heliyon"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-02011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-02011-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-02011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:07:40Z","timestamp":1742195260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-02011-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2011"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-02011-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4421013\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}